Article citationsMore>>

Smith, I., Procter, M., Gelber, R.D., Guillaume, S., Feyereislova, A., et al. (2007) 2-Year Follow-Up of Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer: A Randomised Controlled Trial. The Lancet, 369, 29-36.
https://doi.org/10.1016/S0140-6736(07)60028-2

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top